LGVN
Longeveron Inc.
Phase 2
AI-extracted
laromestrocel (LOMECEL-B®)
hypoplastic left heart syndrome (HLHS)
T-minus 55 days
Aug 31, 2026
SEC 8-K
verified 13h ago
Countdown card →